In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Barracuda Networks, Inc. (NYSE:CUDA), Abraxas Petroleum Corporation (NASDAQ:AXAS), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), Incyte Corporation (NASDAQ:INCY), Forum Energy Technologies, Inc. (NYSE:FET), and S&P Global Inc. (NYSE:SPGI) including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

CUDA DOWNLOAD: http://Fundamental-Markets.com/register/?so=CUDA

AXAS DOWNLOAD: http://Fundamental-Markets.com/register/?so=AXAS

VRTX DOWNLOAD: http://Fundamental-Markets.com/register/?so=VRTX

INCY DOWNLOAD: http://Fundamental-Markets.com/register/?so=INCY

FET DOWNLOAD: http://Fundamental-Markets.com/register/?so=FET

SPGI DOWNLOAD: http://Fundamental-Markets.com/register/?so=SPGI

 (You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Barracuda Networks, Inc. (NYSE:CUDA), Abraxas Petroleum Corporation (NASDAQ:AXAS), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), Incyte Corporation (NASDAQ:INCY), Forum Energy Technologies, Inc. (NYSE:FET), and S&P Global Inc. (NYSE:SPGI) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today’s readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. All information in this release was accessed November 14. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All amounts in millions (except per share amounts).

-----------------------------------------

BARRACUDA NETWORKS, INC. (CUDA) REPORT OVERVIEW

Barracuda Networks' Recent Financial Performance

For the three months ended August 31, 2017 vs August 31, 2016, Barracuda Networks reported revenue of $94.3 vs $87.9 (up 7.3%) and diluted earnings per share $0.03 vs $0.05 (down 40.0%). For the twelve months ended February 28, 2017 vs February 29, 2016, Barracuda Networks reported revenue of $352.6 vs $320.2 (up 10.1%) and diluted earnings per share $0.19 vs -$0.08.

To read the full Barracuda Networks, Inc. (CUDA) report, download it here: http://Fundamental-Markets.com/register/?so=CUDA

-----------------------------------------

ABRAXAS PETROLEUM CORPORATION (AXAS) REPORT OVERVIEW

Abraxas Petroleum's Recent Financial Performance

For the three months ended September 30, 2017 vs September 30, 2016, Abraxas Petroleum reported revenue of $24.72 vs $13.98 (up 76.9%) and diluted earnings per share $0.00 vs -$0.02. For the twelve months ended December 31, 2016 vs December 31, 2015, Abraxas Petroleum reported revenue of $56.6 vs $67.0 (down 15.5%) and diluted earnings per share -$0.79 vs -$1.21.

To read the full Abraxas Petroleum Corporation (AXAS) report, download it here: http://Fundamental-Markets.com/register/?so=AXAS

-----------------------------------------

VERTEX PHARMACEUTICALS INCORPORATED (VRTX) REPORT OVERVIEW

Vertex Pharmaceuticals' Recent Financial Performance

For the three months ended September 30, 2017 vs September 30, 2016, Vertex Pharmaceuticals reported revenue of $578.2 vs $413.8 (up 39.7%) and diluted earnings per share -$0.41 vs -$0.16. For the twelve months ended December 31, 2016 vs December 31, 2015, Vertex Pharmaceuticals reported revenue of $1,702.2 vs $1,032.3 (up 65.0%) and diluted earnings per share -$0.46 vs -$2.31.

To read the full Vertex Pharmaceuticals Incorporated (VRTX) report, download it here: http://Fundamental-Markets.com/register/?so=VRTX

-----------------------------------------

INCYTE CORPORATION (INCY) REPORT OVERVIEW

Incyte's Recent Financial Performance

For the three months ended September 30, 2017 vs September 30, 2016, Incyte reported revenue of $381.5 vs $269.5 (up 41.6%) and diluted earnings per share $0.17 vs $0.19 (down 10.5%). For the twelve months ended December 31, 2016 vs December 31, 2015, Incyte reported revenue of $1,105.7 vs $753.8 (up 46.7%) and diluted earnings per share $0.54 vs $0.03 (up 1700.0%).

To read the full Incyte Corporation (INCY) report, download it here: http://Fundamental-Markets.com/register/?so=INCY

-----------------------------------------

FORUM ENERGY TECHNOLOGIES, INC. (FET) REPORT OVERVIEW

Forum Energy's Recent Financial Performance

For the three months ended September 30, 2017 vs September 30, 2016, Forum Energy reported revenue of $198.7 vs $138.3 (up 43.7%) and diluted earnings per share -$0.15 vs -$0.20. For the twelve months ended December 31, 2016 vs December 31, 2015, Forum Energy reported revenue of $587.6 vs $1,073.7 (down 45.3%) and diluted earnings per share -$0.90 vs -$1.33.

To read the full Forum Energy Technologies, Inc. (FET) report, download it here: http://Fundamental-Markets.com/register/?so=FET

-----------------------------------------

S&P GLOBAL INC. (SPGI) REPORT OVERVIEW

S&P Global's Recent Financial Performance

For the three months ended September 30, 2017 vs September 30, 2016, S&P Global reported revenue of $1,513 vs $1,439 (up 5.1%), diluted earnings per share $1.61 vs $3.36 (down 50.1), and dividends per share $0.41 vs $0.36 (up 13.9%). For the twelve months ended December 31, 2016 vs December 31, 2015, S&P Global reported revenue of $5,661 vs $5,313 (up 6.6%), diluted earnings per share $7.94 vs $4.21 (up 88.6%), and dividends per share $1.44 vs $1.32 (up 9.1%).

To read the full S&P Global Inc. (SPGI) report, download it here: http://Fundamental-Markets.com/register/?so=SPGI

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world’s leading brokerages for over a decade—and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets’ roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets’ oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets’ roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets’ Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@fundamental-markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact: Andrew Duffie, Media Department Office: +1 667-401-0010 E-mail: andrew.duffie@fundamental-markets.com

© 2017 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@fundamental-markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

Vertex Pharmaceuticals (NASDAQ:VRTX)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Vertex Pharmaceuticals Charts.
Vertex Pharmaceuticals (NASDAQ:VRTX)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Vertex Pharmaceuticals Charts.